Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 204

1.

Validation of an algorithm to detect severe MS relapses in administrative health databases.

Marriott JJ, Chen H, Fransoo R, Marrie RA.

Mult Scler Relat Disord. 2017 Dec 2;19:134-139. doi: 10.1016/j.msard.2017.11.022. [Epub ahead of print]

PMID:
29223870
2.

Diet quality is associated with disability and symptom severity in multiple sclerosis.

Fitzgerald KC, Tyry T, Salter A, Cofield SS, Cutter G, Fox R, Marrie RA.

Neurology. 2017 Dec 6. pii: 10.1212/WNL.0000000000004768. doi: 10.1212/WNL.0000000000004768. [Epub ahead of print]

PMID:
29212827
3.

Serum neurofilament light chain in relapsing-remitting MS: Unchaining disease activity prediction?

Marrie RA.

Neurol Neuroimmunol Neuroinflamm. 2017 Nov 28;5(1):e421. doi: 10.1212/NXI.0000000000000421. eCollection 2018 Jan. No abstract available.

4.

Perspectives on marijuana use and effectiveness: A survey of NARCOMS participants.

Cofield SS, Salter A, Tyry T, Crowe C, Cutter GR, Fox RJ, Marrie RA.

Neurol Clin Pract. 2017 Aug;7(4):333-343. doi: 10.1212/CPJ.0000000000000383.

PMID:
29185555
5.

Estimating annual prevalence of depression and anxiety disorder in multiple sclerosis using administrative data.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

BMC Res Notes. 2017 Nov 25;10(1):619. doi: 10.1186/s13104-017-2958-1.

6.

Comorbidity increases the risk of relapse in multiple sclerosis: A prospective study.

Kowalec K, McKay KA, Patten SB, Fisk JD, Evans C, Tremlett H, Marrie RA; CIHR Team in Epidemiology and Impact of Comorbidity on Multiple Sclerosis (ECoMS).

Neurology. 2017 Dec 12;89(24):2455-2461. doi: 10.1212/WNL.0000000000004716. Epub 2017 Nov 8.

PMID:
29117961
7.

Rising incidence of psychiatric disorders before diagnosis of immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

Epidemiol Psychiatr Sci. 2017 Nov 3:1-10. doi: 10.1017/S2045796017000579. [Epub ahead of print]

PMID:
29098977
8.

Increased relapse rate during pregnancy and postpartum in neuromyelitis optica.

Banwell B, Marrie RA.

Neurology. 2017 Nov 28;89(22):2220-2221. doi: 10.1212/WNL.0000000000004721. Epub 2017 Nov 1. No abstract available.

PMID:
29093071
9.

Trigeminal Neuralgia Commonly Precedes the Diagnosis of Multiple Sclerosis.

Fallata A, Salter A, Tyry T, Cutter GR, Marrie RA.

Int J MS Care. 2017 Sep-Oct;19(5):240-246. doi: 10.7224/1537-2073.2016-065.

10.

Effect of adherence to the first-generation injectable immunomodulatory drugs on disability accumulation in multiple sclerosis: a longitudinal cohort study.

Zhang T, Kingwell E, Zhu F, Petkau J, Kastrukoff LF, Marrie RA, Tremlett H, Evans C.

BMJ Open. 2017 Sep 29;7(9):e018612. doi: 10.1136/bmjopen-2017-018612.

11.

Author response: High hypothetical interest in physician-assisted death in multiple sclerosis.

Marrie RA, Salter A, Tyry T, Cutter GR, Fox RJ.

Neurology. 2017 Sep 26;89(13):1429-1430. doi: 10.1212/WNL.0000000000004437. No abstract available.

PMID:
28947584
12.

Preventing multiple sclerosis: To (take) vitamin D or not to (take) vitamin D?

Marrie RA, Beck CA.

Neurology. 2017 Oct 10;89(15):1538-1539. doi: 10.1212/WNL.0000000000004506. Epub 2017 Sep 13. No abstract available.

PMID:
28904085
13.

Caught in a no-win situation: discussions about CCSVI between persons with multiple sclerosis and their neurologists - a qualitative study.

Driedger SM, Maier R, Marrie RA, Brouwers M.

BMC Neurol. 2017 Sep 7;17(1):176. doi: 10.1186/s12883-017-0954-7.

14.

Increased incidence of psychiatric disorders in immune-mediated inflammatory disease.

Marrie RA, Walld R, Bolton JM, Sareen J, Walker JR, Patten SB, Singer A, Lix LM, Hitchon CA, El-Gabalawy R, Katz A, Fisk JD, Bernstein CN; CIHR Team in Defining the Burden and Managing the Effects of Psychiatric Comorbidity in Chronic Immunoinflammatory Disease.

J Psychosom Res. 2017 Oct;101:17-23. doi: 10.1016/j.jpsychores.2017.07.015. Epub 2017 Aug 1.

15.

Persistence to disease-modifying therapies for multiple sclerosis in a Canadian cohort.

Melesse DY, Marrie RA, Blanchard JF, Yu BN, Evans C.

Patient Prefer Adherence. 2017 Jun 28;11:1093-1101. doi: 10.2147/PPA.S138263. eCollection 2017.

16.

Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records.

McKay KA, Evans C, Fisk JD, Patten SB, Fiest K, Marrie RA, Tremlett H.

Neuroepidemiology. 2017;48(3-4):124-130. doi: 10.1159/000477771. Epub 2017 Jul 7.

PMID:
28683461
17.

Depression in multiple sclerosis.

Patten SB, Marrie RA, Carta MG.

Int Rev Psychiatry. 2017 Oct;29(5):463-472. doi: 10.1080/09540261.2017.1322555. Epub 2017 Jul 6.

PMID:
28681616
18.

Markedly increased incidence of critical illness in adults with Type 1 diabetes.

Marrie RA, Sellers EAC, Chen H, Fransoo R, Bernstein CN, Hitchon CA, Peschken CA, Garland A.

Diabet Med. 2017 Oct;34(10):1414-1420. doi: 10.1111/dme.13404. Epub 2017 Jul 12.

PMID:
28626956
19.

Hospitalization is associated with subsequent disability in multiple sclerosis.

Garland A, Metz LM, Bernstein CN, Peschken CA, Hitchon CA, Marrie RA.

Mult Scler Relat Disord. 2017 May;14:23-28. doi: 10.1016/j.msard.2017.03.009. Epub 2017 Mar 24.

20.

Multiple sclerosis in First Nations Canadians: A pilot comparison study.

Marrie RA, Hall N, Sadovnick AD.

Mult Scler J Exp Transl Clin. 2016 Aug 29;2:2055217316666093. doi: 10.1177/2055217316666093. eCollection 2016 Jan-Dec.

Supplemental Content

Loading ...
Support Center